According to Ampio Pharmaceuticals's latest financial reports the company has $4.08 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $12.65 M | -62.67% |
2021-12-31 | $33.89 M | 95.39% |
2020-12-31 | $17.34 M | 165.55% |
2019-12-31 | $6.53 M | -13.88% |
2018-12-31 | $7.58 M | -7.6% |
2017-12-31 | $8.2 M | 63.61% |
2016-12-31 | $5.01 M | -68.64% |
2015-12-31 | $15.99 M | -68.21% |
2014-12-31 | $50.32 M | 91.26% |
2013-12-31 | $26.3 M | 48.79% |
2012-12-31 | $17.68 M | 55.62% |
2011-12-31 | $11.36 M | 1592.64% |
2010-12-31 | $0.67 M | 832.55% |
2009-12-31 | $0.07 M | 2487.46% |
2008-12-31 | $0 M | 74.53% |
2007-12-31 | $0 M | |
2006-12-31 | $N/A |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $22.92 B | 560,599.44% | ๐บ๐ธ USA |
Pfizer PFE | $12.69 B | 310,244.83% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $7.27 B | 177,914.18% | ๐บ๐ธ USA |
Regeneron Pharmaceuticals REGN | $10.84 B | 265,118.88% | ๐บ๐ธ USA |
Rigel Pharmaceuticals RIGL | $56.93 M | 1,292.35% | ๐บ๐ธ USA |
Flexion Therapeutics
FLXN | N/A | N/A | ๐บ๐ธ USA |
Aerie Pharmaceuticals AERI | $0.17 B | 4,117.75% | ๐บ๐ธ USA |